Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

TEM

Tempus AI Inc

Feb 13 • 12:58PM ET

52.10

+1.32 2.60 %

Healthcare • Health Information Services • USA • NASD

Feb 12, 4:12 PMTempus AI announces a non-exclusive distribution and integration agreement with Median Technologies to offer FDA-cleared eyonis LCS lung cancer screening AI through its Pixel platform in the United States.

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK VXF BAI IBB IWP JTEK

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	41.52%	Shs Outstand	172.63M	Perf Week	-5.12%
Market Cap	9.27B	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-2.51%	Shs Float	104.04M	Perf Month	-24.80%
Enterprise Value	9.85B	PEG	-	EPS next Q	-0.04	Inst Own	51.68%	Short Float	20.70%	Perf Quarter	-26.72%
Income	-203.88M	P/S	8.39	EPS this Y	61.78%	Inst Trans	22.09%	Short Ratio	4.43	Perf Half Y	-27.22%
Sales	1.11B	P/B	18.23	EPS next Y	62.41%	ROA	-12.53%	Short Interest	21.54M	Perf YTD	-11.77%
Book/sh	2.86	P/C	12.20	EPS next 5Y	-	ROE	-72.61%	52W High	104.32 -50.06%	Perf Year	-37.79%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-11.13%	52W Low	36.22 43.84%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	60.33%	Volatility	6.55% 6.22%	Perf 5Y	-
Dividend TTM	-	EV/Sales	8.91	EPS Y/Y TTM	76.81%	Oper. Margin	-21.07%	ATR (14)	3.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	72.58%	Profit Margin	-18.45%	RSI (14)	34.71	Recom	1.88
Dividend Gr. 3/5Y	- -	Current Ratio	3.28	EPS Q/Q	0.15%	SMA20	-13.41%	Beta	5.34	Target Price	87.92
Payout	-	Debt/Eq	2.63	Sales Q/Q	84.72%	SMA50	-19.75%	Rel Volume	0.70	Prev Close	50.78
Employees	2400	LT Debt/Eq	2.61	Earnings	Feb 24 AMC	SMA200	-25.65%	Avg Volume	4.87M	Price	52.10
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.16% 1.67%	Trades		Volume	1,891,749	Change	2.60%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Resumed	Morgan Stanley	Overweight	$85
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48

Show Previous Ratings

Today 09:33AM	Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release? (Zacks)
Feb-12-26 09:22PM	Cathie Wood's Ark Scoops Up $12.4 Million In Beaten-Down Robinhood - Dumps More Airbnb Shares (Benzinga) -5.28%
04:05PM	Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform (Business Wire)
04:05PM	Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States (Business Wire)
Feb-11-26 11:13AM	HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? (Zacks)
09:54AM	Loading…
Feb-10-26 09:54AM	Jim Cramer on Tempus (TEM): "It's Going to Go Back Down Again" (Insider Monkey)
08:30AM	Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24 (Business Wire)
Feb-04-26 10:17PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
07:00AM	Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes (Business Wire)
Feb-02-26 07:00AM	Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield (Business Wire)
Feb-01-26 06:50PM	Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others (Motley Fool)
08:30AM	Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones (Insider Monkey)
Jan-29-26 09:25AM	AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift (PR Newswire)
08:47AM	TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom? (Zacks)
Jan-27-26 11:09AM	Nancy Pelosi Just Doubled Down on AI Again (24/7 Wall St.)
08:30AM	Loading…
08:30AM	Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers (Business Wire)
Jan-26-26 08:56PM	Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors (Benzinga)
06:18PM	Pelosi's Bullish 2026 Buy List: AI, Power & Dividends (MarketBeat)
02:21PM	Nancy Pelosi Discloses New Stock Trades: Here's What She's Loading Up On - And What's She's Selling (Benzinga)
01:26PM	Natural Gas Rallies 30%, Silver Jumps 13% To $116: What's Moving Markets Monday? (Benzinga)
10:20AM	Hims & Hers Scales Platform-Led Digital Healthcare Access and Care (Zacks)
09:40AM	How TEM Is Capitalizing on AI-Driven Pathology Market Growth (Zacks)
Jan-22-26 09:06PM	Cathie Wood Loads Up On This Robotaxi Stock, Ark Dumps Roku In Latest Trades (Benzinga)
12:42PM	HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? (Zacks)
10:10AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-21-26 09:06PM	Cathie Wood Doubles Down On Netflix Despite Weak Guidance, Ark Invest Dumps This Social Media Stock (Benzinga)
04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
08:30AM	Tempus Announces the Launch of Paige Predict (Business Wire)
07:57AM	Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention (Zacks)
Jan-20-26 12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga) -5.05%
07:48AM	Loading…
Jan-13-26 07:48AM	Tempus AI (TEM) Soars 15% on $1.1-Billion Deal (Insider Monkey)
07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks)
Jan-12-26 07:27PM	Why Tempus AI Stock Rose Today (Motley Fool)
04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily)
02:53PM	Why Tempus AI Stock Is Trading Higher On Monday? (Benzinga)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
12:43PM	Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday? (Benzinga)
10:58AM	Nancy Pelosi's Latest Trades Are Heating Up - Tempus AI's 100% Stock Surge Is Leading The Charge (Benzinga)
10:56AM	JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop (Investor's Business Daily)
08:30AM	Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology (Business Wire)
07:51AM	Tempus AI Stock Rallies 105% in a Year: Should Investors Still Hold? (Zacks)
07:00AM	Northwestern Medicine Selects Tempus to Expand Genomic Testing (Business Wire)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
05:33AM	Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve-Vistra, Tempus AI, Alibaba In Focus (Benzinga)
Jan-11-26 05:30PM	Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion (Business Wire)
05:00PM	Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results (Business Wire)
Jan-09-26 07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 06:18PM	Inverse Cramer Wins Again: Opposite Picks Of Investor Beat Nancy Pelosi In 2025 (Benzinga)
08:30AM	Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO Gastrointestinal Cancers Symposium (Business Wire)
Jan-07-26 07:33AM	TEM's Stable Solvency and Financial Strength Are Gaining Attention (Zacks)
Jan-06-26 08:30AM	Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference (Business Wire) +7.48%
Jan-05-26 12:43PM	Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization (Zacks)
Jan-02-26 09:10AM	TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader (Insider Monkey) +5.61%
Dec-30-25 11:47PM	Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) (Insider Monkey)
07:32AM	How Tempus AI Is Building Scale While Near-Term Risks Persist (Zacks)
Dec-29-25 08:48AM	TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside (Zacks)
Dec-26-25 07:18AM	How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up (Zacks)
Dec-22-25 10:19PM	BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns (Insider Monkey)
09:53AM	JPMorgan Lowers Tempus AI (TEM) PT to $80, Maintains Neutral Rating (Insider Monkey)
Dec-19-25 07:36AM	Tempus AI Approaching Profitability Despite GAAP Losses (Zacks)
Dec-17-25 11:22AM	Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data (Zacks) -5.13%
Dec-16-25 12:11PM	Hims & Hers Scales Technology-Driven Care as Profitability Evolves (Zacks)
10:40AM	Tempus AI price target lowered to $80 from $90 at BofA (TipRanks)
09:07AM	Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up (Zacks)
08:13AM	3 MedTech Stocks Poised to Gain in 2026 From the AI Boom (Zacks)
Dec-15-25 11:30AM	Tempus AI Near $75 Target? Valuation, Upside and Risks (Zacks)
Dec-11-25 07:10AM	Tempus AI's Strategic Push to Expand Beyond Oncology (Zacks)
Dec-10-25 07:37AM	Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? (Zacks)
Dec-09-25 11:17AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
10:19AM	Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run? (Zacks)
08:30AM	Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium (Business Wire)
Dec-08-25 02:08PM	5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up) (MarketBeat)
10:15AM	Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook (Zacks)
Dec-05-25 09:41AM	Tempus AI: Revenue Mix and 2026 Growth Outlook Explained (Zacks)
09:25AM	Is Tempus AI the Next Big Artificial Intelligence Stock to Buy? (Motley Fool)
08:44AM	Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves (Zacks)
Dec-04-25 11:30AM	Why Is Tempus (TEM) Down 8.9% Since Last Earnings Report? (Zacks)
10:38AM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
Dec-01-25 05:28AM	Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) (Insider Monkey)
Nov-28-25 03:18PM	Why Tempus AI Stock Soared This Week (Motley Fool)
Nov-25-25 12:28PM	Hims & Hers Expands Care Scope as Digital Health Platforms Evolve (Zacks)
07:46AM	Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How (Zacks)
Nov-24-25 07:53AM	TEM vs. BFLY: Which Stock Offers Greater Upside Amid Health Tech Boom? (Zacks) +8.21%
Nov-18-25 08:30AM	Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
Nov-17-25 08:55AM	How Did Tempus AI Power Its Move to Positive EBITDA in Q3? (Zacks)
Nov-15-25 09:00AM	Alphabets Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too? (24/7 Wall St.)
Nov-14-25 12:03PM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
08:30AM	Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research (Business Wire)
07:57AM	TEM Continues to Strengthen Its Genomics Leadership With New Products (Zacks)
Nov-11-25 07:29AM	Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release? (Zacks)
Nov-09-25 10:00PM	Nancy Pelosi posted up a staggering 16,930% return on investment, beat the market by 581%: Here are her 5 biggest wins (Moneywise)
Nov-07-25 12:43PM	Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care (Zacks)
10:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Nov-06-25 01:22PM	Tempus AI: Volatility Equates to Opportunity in AI Leader (MarketBeat) -12.36%
Nov-05-25 11:01AM	TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours (Zacks)
08:30AM	Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025 (Business Wire)
05:25AM	3 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
12:07AM	Tempus AI Inc (TEM) Q3 2025 Earnings Call Highlights: Strong Genomics Growth and Strategic ... (GuruFocus.com)
Nov-04-25 06:30PM	Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Epstein David R	Director	Feb 02 '26	Sale	59.41	370	21,982	26,051	Feb 04 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 28 '26	Sale	65.56	166,250	10,899,207	8,941,533	Jan 30 04:15 PM
Eric Lefkofsky	Officer	Jan 28 '26	Proposed Sale	66.81	166,250	11,107,162		Jan 28 04:21 PM
Fukushima Ryan	Chief Operating Officer	Jan 05 '26	Sale	64.26	5,000	321,300	148,808	Jan 07 06:25 PM
Doudna Jennifer A	Director	Jan 02 '26	Sale	60.17	1,250	75,212	22,702	Jan 06 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '25	Sale	63.99	166,250	10,638,478	8,974,783	Dec 22 05:41 PM
Eric Lefkofsky	Officer	Dec 18 '25	Proposed Sale	64.61	166,250	10,741,413		Dec 18 04:39 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '25	Sale	67.42	1,302	87,781	89,280	Dec 18 04:15 PM
ERIK PHELPS	Officer	Dec 16 '25	Proposed Sale	68.67	1,302	89,408		Dec 16 04:29 PM
Rogers James William	Chief Financial Officer	Dec 11 '25	Sale	73.20	19,966	1,461,479	111,250	Dec 12 04:30 PM
JAMES ROGERS	Officer	Dec 11 '25	Proposed Sale	75.07	19,966	1,498,848		Dec 11 04:23 PM
Frederick Wayne A.I.	Director	Dec 05 '25	Sale	77.23	3,675	283,820	24,836	Dec 09 04:15 PM
WAYNE FREDERICK	Director	Dec 05 '25	Proposed Sale	77.23	3,675	283,802		Dec 05 04:15 PM
Epstein David R	Director	Dec 01 '25	Sale	75.55	250	18,888	26,421	Dec 03 04:50 PM
Fukushima Ryan	Chief Operating Officer	Dec 01 '25	Sale	75.72	5,000	378,620	153,808	Dec 03 04:50 PM
Doudna Jennifer A	Director	Dec 01 '25	Sale	75.55	676	51,072	23,952	Dec 03 04:50 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 24 '25	Sale	74.10	166,250	12,319,125	9,008,033	Nov 25 04:30 PM
Polovin Andrew	EVP and General Counsel	Nov 24 '25	Sale	75.00	12,874	965,550	107,590	Nov 25 04:30 PM
Eric Lefkofsky	Officer	Nov 20 '25	Proposed Sale	70.40	166,250	11,703,285		Nov 24 06:11 PM
ANDREW POLOVIN	Officer	Nov 24 '25	Proposed Sale	70.29	12,874	904,913		Nov 24 04:29 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 20 '25	Sale	68.97	166,250	11,466,099	9,041,283	Nov 20 07:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 18 '25	Sale	65.54	16,829	1,102,944	2,003,213	Nov 20 07:56 PM
Rogers James William	Chief Financial Officer	Nov 18 '25	Sale	65.54	7,257	475,611	131,216	Nov 20 07:05 PM
Polovin Andrew	EVP and General Counsel	Nov 19 '25	Sale	68.06	6,387	434,707	120,464	Nov 20 07:05 PM
Polovin Andrew	EVP and General Counsel	Nov 18 '25	Sale	65.54	5,205	341,126	126,851	Nov 20 07:05 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Nov 18 '25	Sale	65.54	3,533	231,547	90,582	Nov 20 07:05 PM
Fukushima Ryan	Chief Operating Officer	Nov 18 '25	Sale	65.54	10,099	661,870	829,081	Nov 20 07:05 PM
Bartolucci Ryan M	Chief Accounting Officer	Nov 18 '25	Sale	65.54	1,834	120,197	44,061	Nov 20 07:05 PM
Eric Lefkofsky	Officer	Nov 20 '25	Proposed Sale	69.09	166,250	11,486,212		Nov 20 04:46 PM
ANDREW POLOVIN	Officer	Nov 19 '25	Proposed Sale	66.77	6,387	426,460		Nov 19 04:22 PM
Ryan M. Bartolucci	Officer	Nov 18 '25	Proposed Sale	66.39	1,834	121,759		Nov 18 07:09 PM
Ryan Fukushima	Officer	Nov 18 '25	Proposed Sale	66.39	10,099	670,473		Nov 18 07:08 PM
Eric Paul Lefkofsky	Officer	Nov 18 '25	Proposed Sale	66.39	16,829	1,117,277		Nov 18 07:07 PM
Andrew Polovin	Officer	Nov 18 '25	Proposed Sale	66.39	5,205	345,560		Nov 18 07:05 PM
James William Rogers	Officer	Nov 18 '25	Proposed Sale	66.39	7,257	481,792		Nov 18 07:04 PM
Erik Phelps	Officer	Nov 18 '25	Proposed Sale	66.39	3,533	234,556		Nov 18 07:03 PM
Doudna Jennifer A	Director	Nov 11 '25	Sale	71.45	1,926	137,613	24,628	Nov 13 04:15 PM
JENNIFER DOUDNA	Director	Nov 11 '25	Proposed Sale	71.78	3,852	276,497		Nov 12 07:03 AM
Fukushima Ryan	Chief Operating Officer	Nov 03 '25	Sale	89.03	5,000	445,160	125,000	Nov 05 04:15 PM
Epstein David R	Director	Nov 03 '25	Sale	90.00	370	33,300	26,671	Nov 05 04:15 PM
VANESSA L KUBO	Officer	Nov 03 '25	Proposed Sale	89.85	20,000	1,797,000		Nov 03 04:26 PM
DAVID R. EPSTEIN	Director	Nov 03 '25	Proposed Sale	89.85	990	88,952		Nov 03 04:25 PM
LEFKOFSKY ERIC P	CEO and Chairman	Oct 28 '25	Sale	89.11	332,500	29,629,006	9,074,532	Oct 30 04:31 PM
Eric Lefkofsky	Officer	Oct 28 '25	Proposed Sale	91.58	332,500	30,450,350		Oct 28 04:09 PM
Fukushima Ryan	Chief Operating Officer	Oct 06 '25	Sale	92.32	5,000	461,606	130,000	Oct 08 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Sep 25 '25	Sale	76.56	332,500	25,457,014	9,141,032	Sep 29 04:33 PM
Eric Lefkofsky	Officer	Sep 25 '25	Proposed Sale	84.13	332,500	27,973,225		Sep 25 07:04 PM
Fukushima Ryan	Chief Operating Officer	Sep 02 '25	Sale	75.80	10,000	758,028	135,000	Sep 04 04:15 PM
Epstein David R	Director	Sep 02 '25	Sale	73.64	250	18,410	27,041	Sep 04 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 27 '25	Sale	74.10	332,500	24,637,581	9,207,533	Aug 29 05:13 PM
Leonsis Theodore	Director	Aug 26 '25	Sale	75.83	20,000	1,516,600	66,756	Aug 28 04:15 PM
Eric Lefkofsky	Officer	Aug 27 '25	Proposed Sale	75.90	332,500	25,236,750		Aug 27 04:19 PM
Leonsis Theodore	Director	Aug 26 '25	Proposed Sale	75.83	20,000	1,516,650		Aug 26 01:27 PM
Polovin Andrew	EVP and General Counsel	Aug 19 '25	Sale	74.65	5,398	402,982	132,056	Aug 21 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Aug 19 '25	Sale	74.65	3,664	273,532	94,115	Aug 21 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 19 '25	Sale	74.65	17,458	1,303,307	2,020,042	Aug 21 04:15 PM
Fukushima Ryan	Chief Operating Officer	Aug 19 '25	Sale	74.65	17,460	1,303,456	839,180	Aug 21 04:15 PM
Rogers James William	Chief Financial Officer	Aug 19 '25	Sale	74.65	7,528	561,994	138,473	Aug 21 04:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 19 '25	Sale	74.65	1,904	142,141	45,895	Aug 21 04:15 PM
Erik Phelps	Officer	Aug 19 '25	Proposed Sale	78.45	3,664	287,441		Aug 20 07:19 AM
Andrew Polovin	Officer	Aug 19 '25	Proposed Sale	78.45	5,398	423,473		Aug 20 07:17 AM
Ryan Fukushima	Officer	Aug 19 '25	Proposed Sale	78.45	17,460	1,369,737		Aug 20 07:15 AM
Eric Paul Lefkofsky	Officer	Aug 19 '25	Proposed Sale	78.45	17,458	1,369,580		Aug 20 07:14 AM
James William Rogers	Officer	Aug 19 '25	Proposed Sale	78.45	7,528	590,572		Aug 19 09:59 PM
Ryan M. Bartolucci	Officer	Aug 19 '25	Proposed Sale	78.45	1,904	149,369		Aug 19 09:56 PM
Leonsis Theodore	Director	Aug 13 '25	Proposed Sale	69.90	44,000	3,075,786		Aug 18 02:44 PM
Leonsis Theodore	Director	Aug 13 '25	Sale	69.90	44,000	3,075,600	86,756	Aug 15 09:21 PM
Epstein David R	Director	Aug 01 '25	Sale	55.16	370	20,409	27,291	Aug 05 04:15 PM
DAVID R. EPSTEIN	Director	Aug 01 '25	Proposed Sale	56.59	620	35,086		Aug 01 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '25	Sale	62.87	166,250	10,452,027	9,274,033	Jul 30 08:42 PM
Eric Lefkofsky	Officer	Jul 28 '25	Proposed Sale	64.49	166,250	10,721,462		Jul 28 04:13 PM
Fukushima Ryan	Chief Operating Officer	Jul 07 '25	Sale	60.00	5,000	300,000	145,000	Jul 09 04:15 PM
VANESSA L KUBO	Officer	Jul 07 '25	Proposed Sale	60.97	20,000	1,219,400		Jul 07 04:16 PM
Doudna Jennifer A	Director	Jul 01 '25	Sale	62.52	625	39,075	26,554	Jul 03 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 17 '25	Sale	70.07	250,000	17,516,593	9,357,283	Jun 20 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 18 '25	Sale	69.44	250,000	17,359,469	9,307,283	Jun 20 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Jun 16 '25	Sale	72.56	51,317	3,723,634	97,779	Jun 18 04:15 PM
Polovin Andrew	EVP and General Counsel	Jun 16 '25	Sale	72.13	1,423	102,641	137,454	Jun 18 04:15 PM
Eric Paul Lefkofsky	Officer	Jun 17 '25	Proposed Sale	72.00	400,000	28,800,000		Jun 17 09:45 PM
ERIK PHELPS	Officer	Jun 16 '25	Proposed Sale	71.28	51,317	3,657,876		Jun 16 04:30 PM
ANDREW POLOVIN	Officer	Jun 16 '25	Proposed Sale	71.28	1,423	101,431		Jun 16 04:22 PM
Leonsis Theodore	Director	Jun 11 '25	Sale	67.66	205,847	13,927,976	0	Jun 13 04:15 PM
Revolution Growth Management C	Shareholder	Jun 11 '25	Proposed Sale	69.38	205,847	14,281,665		Jun 11 04:02 PM
Fukushima Ryan	Chief Operating Officer	Jun 03 '25	Sale	62.29	20,000	1,245,764	856,640	Jun 05 04:15 PM
Doudna Jennifer A	Director	Jun 02 '25	Sale	55.20	558	30,802	27,179	Jun 04 04:15 PM
Epstein David R	Director	Jun 02 '25	Sale	55.20	250	13,800	27,661	Jun 04 04:15 PM
JENNIFER A DOUDNA	Director	Jun 02 '25	Proposed Sale	55.18	1,183	65,278		Jun 02 04:32 PM
Rogers James William	Chief Financial Officer	May 20 '25	Sale	63.27	23,121	1,462,809	146,001	May 22 08:00 PM
Polovin Andrew	EVP and General Counsel	May 20 '25	Sale	63.43	17,552	1,113,385	138,877	May 22 08:00 PM
Phelps Erik	EVP & Chief Admin & Legal Off	May 20 '25	Sale	63.21	8,415	531,918	149,096	May 22 08:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 20 '25	Sale	63.21	16,752	1,058,905	4,878,837	May 22 08:00 PM
Fukushima Ryan	Chief Operating Officer	May 20 '25	Sale	63.21	7,820	494,308	876,640	May 22 08:00 PM
Bartolucci Ryan M	Chief Accounting Officer	May 20 '25	Sale	63.23	6,073	384,023	47,799	May 22 08:00 PM
Ryan M. Bartolucci	Officer	May 20 '25	Proposed Sale	63.74	4,254	271,150		May 21 07:39 PM
Ryan Fukushima	Officer	May 20 '25	Proposed Sale	63.74	7,820	498,447		May 21 07:36 PM
Andrew Polovin	Officer	May 20 '25	Proposed Sale	63.74	9,797	624,461		May 21 07:25 PM
Eric Paul Lefkofsky	Officer	May 20 '25	Proposed Sale	63.74	16,752	1,067,772		May 21 07:23 PM
Erik Phelps	Officer	May 20 '25	Proposed Sale	63.74	8,415	536,372		May 21 07:20 PM
James William Rogers	Officer	May 20 '25	Proposed Sale	63.74	11,413	727,465		May 21 07:18 PM
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM

Open in Screener

PODD

Insulet Corporation

Feb 13 • 12:58PM ET

245.99

+5.17 2.15 %

Healthcare • Medical Devices • USA • NASD

PODD Insulet Corporation daily Stock Chart

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO VB VO IVV SPY VUG RSP VBK XLV

Index	S&P 500	P/E	71.37	EPS (ttm)	3.45	Insider Own	0.41%	Shs Outstand	70.35M	Perf Week	1.68%
Market Cap	17.30B	Forward P/E	39.52	EPS next Y	6.23	Insider Trans	-2.25%	Shs Float	70.06M	Perf Month	-13.04%
Enterprise Value	17.58B	PEG	1.14	EPS next Q	1.46	Inst Own	101.48%	Short Float	2.76%	Perf Quarter	-26.97%
Income	246.20M	P/S	6.86	EPS this Y	50.72%	Inst Trans	-0.46%	Short Ratio	2.32	Perf Half Y	-22.10%
Sales	2.52B	P/B	12.50	EPS next Y	27.48%	ROA	8.13%	Short Interest	1.93M	Perf YTD	-13.46%
Book/sh	19.68	P/C	22.85	EPS next 5Y	34.68%	ROE	19.68%	52W High	354.88 -30.68%	Perf Year	-12.81%
Cash/sh	10.77	P/FCF	40.85	EPS past 3/5Y	186.88% 98.82%	ROIC	10.62%	52W Low	230.05 6.93%	Perf 3Y	-17.62%
Dividend Est.	-	EV/EBITDA	32.50	Sales past 3/5Y	23.54% 22.92%	Gross Margin	72.11%	Volatility	3.36% 3.36%	Perf 5Y	-15.11%
Dividend TTM	-	EV/Sales	6.97	EPS Y/Y TTM	-41.72%	Oper. Margin	17.32%	ATR (14)	8.78	Perf 10Y	885.14%
Dividend Ex-Date	-	Quick Ratio	2.14	Sales Y/Y TTM	27.12%	Profit Margin	9.76%	RSI (14)	34.67	Recom	1.47
Dividend Gr. 3/5Y	- -	Current Ratio	2.83	EPS Q/Q	14.88%	SMA20	-5.27%	Beta	1.43	Target Price	373.28
Payout	0.00%	Debt/Eq	0.75	Sales Q/Q	29.86%	SMA50	-11.71%	Rel Volume	0.48	Prev Close	240.82
Employees	3900	LT Debt/Eq	0.68	Earnings	Feb 18 BMO	SMA200	-19.27%	Avg Volume	834.06K	Price	245.99
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.75% 4.11%	Trades		Volume	225,099	Change	2.15%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Resumed	TD Cowen	Hold	$294
Jan-12-26	Downgrade	Barclays	Overweight → Equal Weight	$274
Dec-16-25	Initiated	Evercore ISI	Outperform	$370
Nov-19-25	Upgrade	UBS	Neutral → Buy	$400
Oct-21-25	Resumed	Stifel	Buy	$370
Sep-08-25	Resumed	Oppenheimer	Outperform	$365
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343

Show Previous Ratings

Today 11:26AM	Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market (PR Newswire)
Feb-12-26 09:15AM	Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-11-26 10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-10-26 07:40AM	Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates (Zacks)
Feb-05-26 07:00AM	Insulet Launches Omnipod 5 and Omnipod Discover in the Middle East to Transform Diabetes Care (Business Wire)
07:50PM	Loading…
Feb-02-26 07:50PM	Insulet Corporation (PODD): A Bull Case Theory (Insider Monkey)
Jan-30-26 02:31PM	Reasons Why Hedge Funds Favor Insulet Corp (PODD) (Insider Monkey)
Jan-29-26 09:08PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jan-27-26 09:37AM	Target upgraded, Stryker downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Affirm Holdings, Alcoa, Block, Coinbase Global,CoreWeave, Datadog, Intuitive Surgical, and More (24/7 Wall St.)
Jan-26-26 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Jan-23-26 07:30PM	Analyst Report: DexCom, Inc. (Morningstar Research)
Jan-22-26 08:59PM	Analyst Report: DexCom, Inc. (Morningstar Research)
08:24AM	What You Need To Know Ahead of Insulets Earnings Release (Barchart)
Jan-21-26 05:00AM	BVI appoints Jim Hollingshead as CEO (MedTech Dive)
07:20PM	Loading…
Jan-20-26 07:20PM	Is Insulet (PODD) the Future of Diabetes Management? (Motley Fool)
Jan-15-26 05:26AM	JPM26: Insulet presents optimistic growth plan heading into 2026 (Medical Device Network)
Jan-14-26 12:53PM	Bernstein Reduces Firm's PT on Insulet (PODD) Stock (Insider Monkey)
Jan-12-26 09:49AM	Netflix initiated, Palantir upgraded: Wall Street's top analyst calls (The Fly)
Jan-09-26 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
06:00AM	Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 (Business Wire)
Jan-08-26 09:33AM	What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage? (Insider Monkey)
Jan-06-26 07:00AM	Insulet Redefines Diabetes at CES with "Liveable Technology" - A New Frontier in Human-Centered Connected Health (Business Wire)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Dec-31-25 04:54AM	Best Growth Stocks to Buy for December 31st (Zacks)
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-29-25 08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
12:45PM	Loading…
Dec-26-25 12:45PM	3 Reasons Growth Investors Will Love Insulet (PODD) (Zacks)
07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
08:42AM	Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 (Insider Monkey)
07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)
01:50AM	Medtronics diabetes spinoff MiniMed files for IPO (MedTech Dive)
Dec-19-25 09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
Dec-18-25 08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-17-25 07:55AM	Should You Retain Teleflex Stock in Your Portfolio Now? (Zacks)
Dec-16-25 10:32AM	Is Insulet Stock Underperforming the Nasdaq? (Barchart)
07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
07:47AM	TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio (Zacks)
07:00AM	Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-15-25 07:54AM	4 Medical Device Stocks to Buy for Healthy Returns in 2026 (Zacks)
07:00AM	Insulet Expands Omnipod U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future (Business Wire)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-10-25 12:45PM	Here is Why Growth Investors Should Buy Insulet (PODD) Now (Zacks)
Dec-08-25 10:34PM	Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers (StockStory)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-04-25 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
08:34AM	Here's Why You Should Add CONMED Stock to Your Portfolio Now (Zacks)
07:00AM	Insulet Announces FDA 510(k) Clearance of Omnipod 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience (Business Wire)
Dec-01-25 11:34PM	2 Growth Stocks with Explosive Upside and 1 We Find Risky (StockStory) -5.00%
Nov-24-25 12:45PM	Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
05:47AM	Insulet unveils plans for new diabetes devices (MedTech Dive)
05:15AM	Zacks.com featured highlights include Insulet, Sandisk and O-I Glass (Zacks)
Nov-21-25 06:36PM	Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know (StockStory) +5.84%
Nov-20-25 12:30PM	Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day (Business Wire) -9.66%
07:56AM	Insulet Stock: Is Wall Street Bullish or Bearish? (Barchart)
07:03AM	3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns (Zacks)
Nov-19-25 01:45PM	Medtronic Stock Sees RS Rating Pumps Higher (Investor's Business Daily)
09:44AM	DoorDash, Baidu upgraded: Wall Street's top analyst calls (The Fly)
Nov-18-25 11:03PM	3 Reasons We Love Insulet (PODD) (StockStory)
09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
09:31AM	Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs (Zacks)
04:01AM	Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion (Zacks)
Nov-17-25 10:23AM	Do Options Traders Know Something About Insulet Stock We Don't? (Zacks)
09:20AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
Nov-13-25 12:20PM	Why Insulet (PODD) Might be Well Poised for a Surge (Zacks)
12:06PM	The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout (Investor's Business Daily)
10:00AM	Best Momentum Stocks to Buy for Nov. 13 (Zacks)
08:46AM	Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
05:09AM	New Strong Buy Stocks for Nov. 13: PODD, PRAA, and More (Zacks)
Nov-12-25 05:54AM	Zacks.com featured highlights include Insulet, Celestica and Innodata (Zacks)
Nov-11-25 11:37PM	1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds (StockStory)
03:00PM	3 Top Momentum Stocks to Buy as U.S. Shutdown Nears End (Zacks)
Nov-10-25 12:00PM	Insulet (PODD) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Nov-07-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD) (Zacks)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-06-25 05:10PM	Analyst Report: Insulet Corporation (Morningstar Research)
04:06PM	Insulet Stock Goes On A Wild Journey Following Its Beat-And-Raise Quarter (Investor's Business Daily)
11:42AM	Insulet Sheds Early Gains, Sinking Despite Its Broad Omnipod Beat (Investor's Business Daily)
09:30AM	Insulet (PODD) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:43AM	Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter (Investor's Business Daily)
07:40AM	Insulet (PODD) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:45AM	Insulet's (NASDAQ:PODD) Q3: Strong Sales (StockStory)
06:35AM	Insulet: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Insulet Reports Third Quarter 2025 Results (Business Wire)
Nov-04-25 10:20PM	Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow (StockStory)
02:09PM	Final Trades: Insulet Corp, Uber and Apollo Global (CNBC TV)
09:15AM	Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Nov-03-25 12:08PM	Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings? (Zacks)
Oct-31-25 10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Frederick Wayne A.I.	Director	Dec 15 '25	Sale	293.09	1,851	542,510	2,158	Dec 16 04:04 PM
Frederick Wayne A.I.	Director	Dec 15 '25	Proposed Sale	293.09	1,851	542,500		Dec 15 03:03 PM
STONESIFER TIMOTHY C.	Director	Dec 05 '25	Buy	311.73	962	299,884	4,591	Dec 08 04:02 PM
Manea Dan	Former Officer	Nov 26 '25	Proposed Sale	326.64	4,475	1,461,716		Nov 26 04:31 PM
Manea Dan	Former Officer	Nov 24 '25	Proposed Sale	340.95	2,306	786,228		Nov 24 04:06 PM
Manea Dan	Former Officer	Sep 16 '25	Proposed Sale	337.73	1,347	454,920		Sep 16 01:21 PM
Singh Prem	SVP, Global Operations	Sep 08 '25	Sale	347.49	687	238,726	3,456	Sep 09 04:19 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Option Exercise	241.10	797	192,160	4,687	Sep 09 04:16 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Sale	348.81	797	278,002	3,890	Sep 09 04:16 PM
Cousin Laetitia	Officer	Sep 08 '25	Proposed Sale	348.81	797	278,000		Sep 08 02:07 PM
Singh Prem	Officer	Sep 08 '25	Proposed Sale	347.48	687	238,718		Sep 08 01:31 PM
Benjamin Eric	EVP, CPXO	Aug 21 '25	Sale	332.23	4,263	1,416,296	16,736	Aug 22 04:16 PM
Benjamin Eric	Officer	Aug 21 '25	Proposed Sale	332.23	4,263	1,416,296		Aug 21 10:21 AM
Singh Prem	SVP, Global Operations	Aug 07 '25	Option Exercise	271.28	1,343	364,325	5,486	Aug 08 04:03 PM
Singh Prem	SVP, Global Operations	Aug 07 '25	Sale	320.00	1,343	429,760	4,143	Aug 08 04:03 PM
Singh Prem	Officer	Aug 07 '25	Proposed Sale	320.00	1,343	429,760		Aug 07 11:35 AM
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Hopfield Jessica	Director	May 13 '25	Option Exercise	28.87	5,235	151,134	32,152	May 14 04:15 PM
Hopfield Jessica	Director	May 13 '25	Sale	317.54	5,235	1,662,322	26,917	May 14 04:15 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Option Exercise	92.11	3,001	276,422	23,907	May 14 04:08 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Sale	320.00	3,001	960,320	20,906	May 14 04:08 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM
Field Mark N	Former Officer	May 13 '25	Proposed Sale	321.31	2,457	789,459		May 13 01:44 PM
Benjamin Eric	Officer	May 13 '25	Proposed Sale	320.00	3,001	960,320		May 13 12:51 PM
Hopfield Jessica	Director	May 13 '25	Proposed Sale	317.54	5,235	1,662,322		May 13 10:19 AM
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM

Open in Screener

WDAY

Workday Inc

Feb 13 • 12:58PM ET

145.54

+1.50 1.04 %

Technology • Software - Application • USA • NASD

Peers: MSFT CRM ADBE ORCL NOW SAP INTU PAYC TEAM ZS

| Held by: VTI VOO QQQ VUG VO IVV VGT SPY XLK MOAT

Index	NDX, S&P 500	P/E	61.11	EPS (ttm)	2.38	Insider Own	19.63%	Shs Outstand	214.41M	Perf Week	-10.67%
Market Cap	38.28B	Forward P/E	13.57	EPS next Y	10.72	Insider Trans	-1.65%	Shs Float	211.37M	Perf Month	-24.98%
Enterprise Value	35.22B	PEG	0.63	EPS next Q	2.32	Inst Own	78.08%	Short Float	4.58%	Perf Quarter	-35.58%
Income	642.00M	P/S	4.16	EPS this Y	24.42%	Inst Trans	3.88%	Short Ratio	2.66	Perf Half Y	-34.42%
Sales	9.21B	P/B	4.33	EPS next Y	18.07%	ROA	3.76%	Short Interest	9.69M	Perf YTD	-32.24%
Book/sh	33.58	P/C	5.59	EPS next 5Y	21.47%	ROE	7.34%	52W High	281.00 -48.21%	Perf Year	-44.05%
Cash/sh	26.05	P/FCF	14.81	EPS past 3/5Y	156.63% -	ROIC	5.11%	52W Low	140.59 3.52%	Perf 3Y	-22.69%
Dividend Est.	-	EV/EBITDA	29.08	Sales past 3/5Y	17.81% 18.37%	Gross Margin	75.56%	Volatility	5.00% 4.18%	Perf 5Y	-48.27%
Dividend TTM	-	EV/Sales	3.83	EPS Y/Y TTM	-60.76%	Oper. Margin	9.45%	ATR (14)	7.88	Perf 10Y	195.51%
Dividend Ex-Date	-	Quick Ratio	1.77	Sales Y/Y TTM	13.35%	Profit Margin	6.97%	RSI (14)	24.53	Recom	1.68
Dividend Gr. 3/5Y	- -	Current Ratio	1.77	EPS Q/Q	30.53%	SMA20	-14.84%	Beta	1.16	Target Price	261.92
Payout	0.00%	Debt/Eq	0.43	Sales Q/Q	12.82%	SMA50	-26.02%	Rel Volume	0.95	Prev Close	144.04
Employees	20400	LT Debt/Eq	0.41	Earnings	Feb 24 AMC	SMA200	-35.81%	Avg Volume	3.65M	Price	145.54
IPO	Oct 12, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.10% 0.62%	Trades		Volume	1,936,662	Change	1.04%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-26	Resumed	Goldman	Neutral	$238
Dec-17-25	Resumed	BTIG Research	Buy	$285
Dec-02-25	Initiated	Rosenblatt	Neutral	$235
Nov-21-25	Initiated	Raymond James	Mkt Perform
Sep-17-25	Upgrade	Piper Sandler	Underweight → Neutral	$235
Sep-17-25	Upgrade	Guggenheim	Neutral → Buy	$285
Aug-22-25	Reiterated	Oppenheimer	Outperform	$300 → $270
Aug-22-25	Reiterated	BMO Capital Markets	Outperform	$314 → $285
Aug-14-25	Initiated	Cantor Fitzgerald	Overweight	$265
Jul-10-25	Downgrade	Piper Sandler	Neutral → Underweight	$235
Feb-27-25	Reiterated	BMO Capital Markets	Outperform	$300 → $314
Feb-19-25	Initiated	Redburn Atlantic	Neutral
Feb-19-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$330 → $275
Jan-08-25	Upgrade	Deutsche Bank	Hold → Buy	$265 → $300
Jan-06-25	Upgrade	Guggenheim	Sell → Neutral
Nov-27-24	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $270
Nov-19-24	Initiated	Scotiabank	Sector Outperform	$340
May-24-24	Reiterated	BMO Capital Markets	Outperform	$338 → $300
Feb-27-24	Reiterated	Needham	Buy	$300 → $350
Jan-10-24	Resumed	DA Davidson	Neutral	$300

Show Previous Ratings

Today 10:44AM	From software to real estate, U.S. sectors under the grip of AI scare trade (Reuters)
08:55AM	Arista Tops Q4 Earnings Estimates on Solid Revenues, Record Net Income (Zacks)
12:05AM	Workday shed $40 billion in value. Cofounder Aneel Bhusri is back with a $139 million bet he can turn it around (Fortune)
Feb-12-26 06:54AM	UBS Cuts PT on Workday (WDAY) to $170 From $240, Maintains a Neutral Rating (Insider Monkey)
06:02AM	3 factors that will separate the SaaSpocalypse winners from losers (Fortune)
06:30PM	Loading…
Feb-11-26 06:30PM	Payroll software maker Paycom forecasts weak 2026 revenue, shares fall (February 11) (Reuters) -5.66%
04:03PM	3 HCM Stocks to Consider After January's Strong U.S. Jobs Report (Zacks)
03:55PM	Can a New CEO Save Workday Stock from the Software Apocalypse? (Barchart)
12:56PM	Surviving the SaaS-pocalypse: JPMorgans 3 Top Cyber Stocks Ready to Surge (24/7 Wall St.)
11:23AM	Stocks Turn Mixed as Software Stocks Slide (Barchart)
09:33AM	AI Disruption Overblown! 4 Software Stocks to Buy on the Dip (MarketBeat)
08:30AM	Insperity, Inc. Q4 2025 Earnings Call Summary (Moby)
12:01AM	Insperity Inc (NSP) Q4 2025 Earnings Call Highlights: Strategic Moves and Challenges in Focus (GuruFocus.com)
Feb-10-26 10:58AM	Jim Cramer Notes Worday Stock Has Fallen Significantly From Its Highs (Insider Monkey)
09:45AM	Here's Why Workday (WDAY) is a Strong Growth Stock (Zacks)
09:35AM	Loading…
09:35AM	Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Workday (WDAY) (Zacks)
Feb-09-26 04:34PM	Stocks Settle Higher on Strength in Tech (Barchart) -5.13%
04:10PM	Nasdaq powers ahead, Dow Jones notches new closing record (Proactive)
03:46PM	Workday CEO shift, AppLovin stock surges on short-seller apology (Yahoo Finance Video)
03:39PM	Nasdaq powers ahead as Dow adds to gains in afternoon trading (Proactive)
02:15PM	Workday Stock Falls. Wall Street Isn't Taking Kindly to Co-Founder's Return as CEO. (Barrons.com)
02:13PM	Stock Market Today: Dow Firm As Oracle Soars On This; Hims & Hers Shares Crater On Novo Move (Live Coverage) (Investor's Business Daily)
01:15PM	Workday CEO Eschenbach departs, with co-founder Aneel Bhusri returning as CEO (TechCrunch)
12:43PM	Workday announces CEO change, shares drop as analysts flag questionable timing (Proactive)
12:29PM	Workday's stock falls as CEO change sounds like 'really bad news' to this analyst (MarketWatch)
11:08AM	Workday Changes CEO. Cofounder Bhusri Returns Amid Worries Over AI. (Investor's Business Daily)
11:06AM	Stock Market Today: Dow Gains As Nvidia Jumps; Apple Lags, Energy Stock Tests Entry (Live Coverage) (Investor's Business Daily)
10:47AM	Workday co-founder Aneel Bhusri returns as CEO amid stock slump (Investing.com)
10:01AM	Stocks Slip Ahead of this Week's US News on Jobs and Inflation (Barchart)
09:44AM	Stock Market Today: Dow Falls As Jobs Report Looms; AI Player Monday Plunges On Earnings (Live Coverage) (Investor's Business Daily)
09:13AM	Loading…
09:13AM	Goldman issues a blunt warning to beat-up software stock investors (Yahoo Finance)
09:06AM	Workday Stock Falls Amid CEO Change. Co-Founder Bhusri Returns To Lead Software Maker. (Investor's Business Daily)
08:30AM	Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter (PR Newswire)
06:03AM	US software stocks tumble sparks concerns that AI trade is reshaping markets (Reuters)
Feb-08-26 03:48AM	Why is Workday (WDAY) One of the Most Promising Future Stocks to Buy Now? (Insider Monkey)
Feb-07-26 07:30AM	Software stocks have been crushed. Here's how to play the sector as the dust settles. (MarketWatch)
Feb-06-26 05:45PM	Workday (WDAY) Outperforms Broader Market: What You Need to Know (Zacks) -5.13%
09:30AM	Is Workday (WDAY) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:00AM	Here is What to Know Beyond Why Workday, Inc. (WDAY) is a Trending Stock (Zacks)
Feb-05-26 03:40PM	Workday, Varonis Systems, Five9, SoundHound AI, and C3.ai Shares Are Falling, What You Need To Know (StockStory) -6.69%
12:45PM	Anthropic releases AI upgrade as market punishes software stocks (Reuters)
09:09AM	Strength Seen in Workday (WDAY): Can Its 5.6% Jump Turn into More Strength? (Zacks)
05:33AM	Stock Market Today: Dow Jones Futures Fall, Nasdaq Gains Day After Tech Selloff-Alphabet, Broadcom, Amazon In Focus (Benzinga)
Feb-04-26 01:26PM	Do Stock Sell-Offs Pay Off? These Experts Warn Not to Bottom Feed on New Lows (Investopedia) +5.57%
11:49AM	AI Won't Kill the Software Business, Just Its Growth Story (The Wall Street Journal)
07:58AM	Why the AI-driven software stock crash probably isn't over (Yahoo Finance)
03:26AM	Heard on the Street Tuesday Recap: Code Red (The Wall Street Journal)
Feb-03-26 05:14PM	Heard on the Street Recap: Code Red (The Wall Street Journal) -7.04%
03:15PM	Stocks and bitcoin sink as investors dump software company shares (NBC News)
08:31AM	Workday Introduces the Military Skills Mapper to Help Organizations Better Recognize and Hire Veteran Talent (PR Newswire)
08:30AM	Workday Announces Date of Fiscal 2026 Fourth Quarter and Full Year Financial Results on February 24th, 2026 (PR Newswire)
Feb-02-26 07:04AM	What CFOs at Adobe, Dataminr, and Huntington say about scaling AI (Fortune)
Feb-01-26 02:38AM	Here's What Wall Street Thinks About ?Workday, Inc (WDAY) (Insider Monkey)
Jan-30-26 09:10AM	Workday's (WDAY) AI Strategy Still Developing, 2026 Seen as Critical (Insider Monkey)
08:51AM	Does Workday (WDAY) Offer a Compelling Risk/Reward Opportunity? (Insider Monkey)
Jan-29-26 05:50PM	Workday (WDAY) Declines More Than Market: Some Information for Investors (Zacks) -7.65%
05:49PM	Why Was the Market Down Today? (The Wall Street Journal)
04:15PM	Stocks Slip as Gold, Silver Hit New Records (The Wall Street Journal)
03:49PM	Software stocks suffer worst day in 10 months, widening the gap with hot chip stocks (MarketWatch)
03:09PM	Why Is the Market Down Today? (The Wall Street Journal)
01:48PM	2 Artificial Intelligence Stocks (AI) That Could Still Soar by Over 40%, According to Analysts (Motley Fool)
09:40AM	Stock Market Today: Dow Rises As Microsoft Dives On Earnings; Meta, Tesla Rally (Live Coverage) (Investor's Business Daily)
08:56AM	Software stocks fall premarket as Microsoft and SAP results weigh (Investing.com)
Jan-28-26 11:30PM	3 Software Stocks We Steer Clear Of (StockStory)
04:13PM	ServiceNow stock falls despite earnings beat as CEO Bill McDermott tries to get investors to stop thinking of it as a SaaS company (Fortune)
04:05PM	Workiva Announces Two New Appointments to Board of Directors (Business Wire)
03:19AM	Workday (WDAY) Sale Reflects Slowing Momentum in Enterprise Software (Insider Monkey)
Jan-27-26 11:34PM	3 S&P 500 Stocks We're Skeptical Of (StockStory)
12:00PM	All You Need to Know About Workday (WDAY) Rating Upgrade to Buy (Zacks)
Jan-26-26 11:32AM	Job applicants cant bring disparate impact age bias claims, Workday argues (HR Dive)
09:58AM	Workday (WDAY) Announces Plans to Invest CA$1 billion in Canada (Insider Monkey)
09:40AM	MSI's Silvus Unveils Advanced Radio Systems: Will it Boost Prospects? (Zacks)
09:18AM	Tech stocks are confronting a challenge they haven't had to worry about in a while (Yahoo Finance)
Jan-23-26 06:04AM	The U.S. was the operating system of the world, Scott Galloway says, but now the American brand is chaos, corruption, and coercion (Fortune)
Jan-22-26 05:50PM	Workday (WDAY) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:52AM	Workday CEO: AI is a 'tailwind' for us (CNBC TV)
11:19AM	Workday CEO dismisses concerns that AI is destroying software (Investing.com)
08:52AM	Workday CEO Carl Eschenbach: AI is a tailwind for us, 'absolutely not' a headwind (CNBC TV)
Jan-21-26 08:28AM	Almost half of the time saved using AI is spent correcting outputs (CFO.com)
05:45AM	What You Need To Know Ahead of Workdays Earnings Release (Barchart)
Jan-20-26 01:20PM	ServiceNow Teams Up With OpenAI in Three Year AI Integration Deal (GuruFocus.com)
01:00PM	AI & Business Newsletter Will AI Really Kill Software? (The Wall Street Journal)
12:50PM	Workday pledges CAD $1 billion expansion in Canadian tech sector (Investing.com)
10:22AM	Workday, Inc. (WDAY): A Bull Case Theory (Insider Monkey)
08:47AM	ServiceNow shares rise after WSJ reports three-year AI deal with OpenAI (Investing.com)
08:00AM	Workday to Invest CAD $1 Billion in Canada Over Five Years (PR Newswire)
Jan-19-26 07:49AM	Goldman Sachs Initiates Workday (WDAY) at Neutral as Challenging Market Share Gains Temper AI Optimism (Insider Monkey)
Jan-18-26 07:05PM	Software Stocks Are in Turmoil. Here Are 5 to Buy Right Now. (Motley Fool)
07:26AM	The Cloud Computing ETF Every Growth Investor Should Consider (MarketBeat)
Jan-16-26 05:18PM	Stocks to Watch Friday Recap: J.B. Hunt, Salesforce, PNC (The Wall Street Journal)
03:04PM	Barclays Lowers Firm's PT on Workday, Inc. (WDAY) Stock (Insider Monkey)
09:30AM	Brokers Suggest Investing in Workday (WDAY): Read This Before Placing a Bet (Zacks)
Jan-14-26 05:01PM	Billionaire Investor Dumps Workday Stake, And It's Not The First Time (Benzinga)
11:38AM	The Worries Deepen for Software Stocks (Barrons.com)
08:00AM	25 Stocks to Target (and Avoid) After MLK Day (Schaeffer's Research)
05:30AM	New Workday Research: Companies Are Leaving AI Gains on the Table (PR Newswire)
Jan-13-26 05:50PM	Workday (WDAY) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
04:35PM	Stocks Fall on Weakness in Software and Credit Card Companies (Barchart)
11:00AM	Google Momentum Continues Amid Apple Deal As Software Stocks Hammered (Investor's Business Daily)
06:00AM	From Nvidia to Salesforce: Where money is made in Enterprise AI (Yahoo Finance Video)

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DUFFIELD DAVID A	10% Owner	Jan 08 '26	Sale	209.75	82,884	17,385,197	105,049	Jan 09 07:50 PM
Garfield Mark S.	Chief Accounting Officer	Jan 08 '26	Sale	209.56	953	199,711	35,336	Jan 09 07:49 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 08 '26	Proposed Sale	211.14	82,884	17,500,128		Jan 08 04:23 PM
MARK GARFIELD	Officer	Jan 08 '26	Proposed Sale	211.14	953	201,216		Jan 08 04:22 PM
Eschenbach Carl M.	CEO	Jan 05 '26	Sale	210.00	3,125	656,250	17,097	Jan 07 06:58 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Jan 06 '26	Sale	208.73	3,759	784,626	105,167	Jan 07 05:21 PM
Enslin Robert	President, CCO	Jan 05 '26	Sale	210.17	22,185	4,662,713	106,330	Jan 07 05:20 PM
Rowe Zane	Chief Financial Officer	Jan 06 '26	Sale	208.75	6,000	1,252,492	159,158	Jan 07 05:16 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Jan 06 '26	Sale	210.00	1,130	237,300	85,398	Jan 07 05:15 PM
ZANE ROWE	Officer	Jan 06 '26	Proposed Sale	208.90	6,000	1,253,400		Jan 06 04:32 PM
GERRIT KAZMAIER	Officer	Jan 06 '26	Proposed Sale	208.90	3,759	785,255		Jan 06 04:30 PM
RICHARD SAUER	Officer	Jan 06 '26	Proposed Sale	208.90	1,130	236,057		Jan 06 04:25 PM
DUFFIELD DAVID A	10% Owner	Jan 02 '26	Sale	205.29	81,479	16,727,042	105,049	Jan 06 04:23 PM
C ESCHENBACH JR. & A ESCHENBAC	Director	Jan 05 '26	Proposed Sale	205.79	3,125	643,094		Jan 05 04:41 PM
Enslin Robert	Officer	Jan 05 '26	Proposed Sale	205.80	22,185	4,565,673		Jan 05 04:07 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 02 '26	Proposed Sale	214.78	81,479	17,500,060		Jan 02 04:26 PM
DUFFIELD DAVID A	10% Owner	Dec 23 '25	Sale	215.04	80,279	17,262,992	105,049	Dec 29 04:42 PM
Kazmaier Gerrit S	President, Prod. and Tech.	Dec 19 '25	Sale	218.77	6,547	1,432,258	111,353	Dec 23 04:27 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 23 '25	Proposed Sale	217.99	80,279	17,500,019		Dec 23 04:20 PM
GERRIT KAZMAIER	Officer	Dec 19 '25	Proposed Sale	218.08	6,547	1,427,770		Dec 19 04:21 PM
DUFFIELD DAVID A	10% Owner	Dec 16 '25	Sale	215.98	81,434	17,588,334	105,049	Dec 18 04:19 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 16 '25	Proposed Sale	214.90	81,434	17,500,167		Dec 16 04:31 PM
The Dave & Cheryl Duffield Fou	10% Owner	Dec 15 '25	Proposed Sale	224.49	15,000	3,367,350		Dec 15 04:14 PM
DUFFIELD DAVID A	10% Owner	Dec 02 '25	Sale	212.19	82,025	17,404,800	105,049	Dec 04 04:25 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 02 '25	Proposed Sale	213.35	82,025	17,500,034		Dec 02 04:25 PM
Garfield Mark S.	Chief Accounting Officer	Oct 09 '25	Sale	238.96	1,915	457,601	37,351	Oct 14 04:34 PM
MCNAMARA MICHAEL M	Director	Oct 10 '25	Sale	235.16	5,393	1,268,201	24,078	Oct 14 04:32 PM
DUFFIELD DAVID A	10% Owner	Oct 08 '25	Sale	236.34	75,053	17,738,401	102,997	Oct 10 04:31 PM
Michael McNamara	Director	Oct 10 '25	Proposed Sale	235.16	5,393	1,268,201		Oct 10 04:20 PM
MARK GARFIELD	Officer	Oct 09 '25	Proposed Sale	238.25	1,915	456,249		Oct 09 04:18 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 08 '25	Proposed Sale	233.17	75,053	17,500,108		Oct 08 04:20 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Oct 07 '25	Sale	235.87	2,320	547,220	90,077	Oct 07 07:41 PM
Rowe Zane	Chief Financial Officer	Oct 07 '25	Sale	232.62	6,000	1,395,717	168,468	Oct 07 06:48 PM
RICHARD SAUER	Officer	Oct 07 '25	Proposed Sale	238.36	2,320	552,995		Oct 07 04:41 PM
Eschenbach Carl M.	CEO	Oct 01 '25	Sale	237.52	6,250	1,484,504	20,222	Oct 03 06:43 PM
DUFFIELD DAVID A	10% Owner	Oct 01 '25	Sale	235.09	72,696	17,090,277	102,997	Oct 03 04:23 PM
ESCHENBACH FAMILY TRUST	Director	Oct 01 '25	Proposed Sale	240.73	6,250	1,504,562		Oct 01 04:28 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 01 '25	Proposed Sale	240.73	72,696	17,500,108		Oct 01 04:28 PM
DUFFIELD DAVID A	10% Owner	Sep 23 '25	Sale	241.57	72,118	17,421,401	102,997	Sep 25 04:15 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 23 '25	Proposed Sale	242.66	72,118	17,500,154		Sep 23 04:21 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Sep 17 '25	Sale	235.41	1,160	273,076	95,756	Sep 19 04:32 PM
DUFFIELD DAVID A	10% Owner	Sep 16 '25	Sale	220.12	78,564	17,293,603	102,997	Sep 17 04:28 PM
DUFFIELD DAVID A	10% Owner	Sep 15 '25	Sale	222.23	15,000	3,333,516	15,000	Sep 17 04:28 PM
RICHARD SAUER	Officer	Sep 17 '25	Proposed Sale	219.01	1,160	254,052		Sep 17 04:24 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 16 '25	Proposed Sale	222.75	78,564	17,500,131		Sep 16 04:26 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Sep 11 '25	Sale	226.63	1,160	262,891	96,916	Sep 15 04:34 PM
The Dave & Cheryl Duffield Fou	10% Owner	Sep 15 '25	Proposed Sale	223.39	15,000	3,350,850		Sep 15 04:33 PM
RICHARD SAUER	Officer	Sep 11 '25	Proposed Sale	226.48	1,160	262,717		Sep 11 04:23 PM
DUFFIELD DAVID A	10% Owner	Sep 02 '25	Sale	228.16	75,817	17,298,267	102,997	Sep 04 04:15 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 02 '25	Proposed Sale	230.82	75,817	17,500,080		Sep 02 04:40 PM
Garfield Mark S.	Chief Accounting Officer	Jul 10 '25	Sale	234.86	451	105,922	42,977	Jul 14 04:21 PM
DUFFIELD DAVID A	10% Owner	Jul 08 '25	Sale	239.61	72,551	17,384,110	102,997	Jul 10 04:34 PM
MARK GARFIELD	Officer	Jul 10 '25	Proposed Sale	240.17	451	108,317		Jul 10 04:30 PM
Rowe Zane	Chief Financial Officer	Jul 08 '25	Sale	239.59	6,000	1,437,565	178,418	Jul 08 06:23 PM
ZANE ROWE	Officer	Jul 08 '25	Proposed Sale	241.21	12,000	2,894,520		Jul 08 04:23 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 08 '25	Proposed Sale	241.21	72,551	17,500,027		Jul 08 04:21 PM
Eschenbach Carl M.	CEO	Jul 01 '25	Sale	239.43	6,250	1,496,435	1,472	Jul 03 04:52 PM
DUFFIELD DAVID A	10% Owner	Jul 01 '25	Sale	238.96	72,917	17,424,176	102,997	Jul 03 04:39 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 01 '25	Proposed Sale	240.00	72,917	17,500,080		Jul 01 04:23 PM
DUFFIELD DAVID A	10% Owner	Jun 24 '25	Sale	238.66	73,971	17,654,071	102,997	Jun 26 04:35 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 24 '25	Proposed Sale	236.58	73,971	17,500,059		Jun 24 04:25 PM
DUFFIELD DAVID A	10% Owner	Jun 17 '25	Sale	244.31	71,240	17,404,482	102,997	Jun 18 04:36 PM
DUFFIELD DAVID A	10% Owner	Jun 16 '25	Sale	245.33	15,000	3,679,932	30,000	Jun 18 04:36 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 17 '25	Proposed Sale	245.65	71,240	17,500,106		Jun 17 04:21 PM
The Dave & Cheryl Duffield Fou	10% Owner	Jun 16 '25	Proposed Sale	244.54	15,000	3,668,100		Jun 16 04:32 PM
STILL GEORGE J JR	Director	Jun 05 '25	Sale	248.41	7,500	1,863,101	67,500	Jun 09 04:46 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Jun 05 '25	Proposed Sale	249.48	7,500	1,871,100		Jun 05 05:04 PM
DUFFIELD DAVID A	10% Owner	Jun 02 '25	Sale	246.84	70,648	17,438,932	102,997	Jun 03 04:29 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 02 '25	Proposed Sale	247.71	70,648	17,500,216		Jun 02 04:28 PM
Eschenbach Carl M.	CEO	May 27 '25	Sale	241.23	3,125	753,844	7,722	May 29 06:38 PM
ESCHENBACH FAMILY TRUST	Director	May 27 '25	Proposed Sale	238.01	9,375	2,231,344		May 27 04:34 PM
SAYAN CHAKRABORTY	Officer	May 27 '25	Proposed Sale	238.01	12,860	3,060,809		May 27 04:30 PM
Garfield Mark S.	Chief Accounting Officer	Apr 10 '25	Sale	226.55	497	112,595	34,385	Apr 14 06:38 PM
DUFFIELD DAVID A	10% Owner	Apr 08 '25	Sale	214.68	81,275	17,448,053	102,997	Apr 10 04:37 PM
MARK GARFIELD	Officer	Apr 10 '25	Proposed Sale	231.42	497	115,016		Apr 10 04:17 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 08 '25	Proposed Sale	215.32	81,275	17,500,133		Apr 08 04:16 PM
Eschenbach Carl M.	CEO	Apr 02 '25	Sale	234.61	3,125	733,161	10,847	Apr 04 06:14 PM
DUFFIELD DAVID A	10% Owner	Apr 01 '25	Sale	232.94	74,937	17,455,544	102,997	Apr 03 04:08 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 01 '25	Proposed Sale	233.53	74,937	17,500,038		Apr 01 04:26 PM
DUFFIELD DAVID A	10% Owner	Mar 24 '25	Sale	250.26	70,144	17,554,502	102,997	Mar 26 04:58 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 24 '25	Proposed Sale	249.49	70,144	17,500,227		Mar 24 04:22 PM
DUFFIELD DAVID A	10% Owner	Mar 17 '25	Sale	248.58	71,672	17,816,346	102,997	Mar 18 07:00 PM
DUFFIELD DAVID A	10% Owner	Mar 14 '25	Sale	243.17	15,000	3,647,531	45,000	Mar 18 07:00 PM
STILL GEORGE J JR	Director	Mar 13 '25	Sale	241.33	7,500	1,809,991	75,000	Mar 17 07:16 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 17 '25	Proposed Sale	244.17	71,672	17,500,152		Mar 17 04:32 PM
The Dave & Cheryl Duffield Fou	10% Owner	Mar 14 '25	Proposed Sale	237.22	15,000	3,558,300		Mar 14 04:25 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Mar 13 '25	Proposed Sale	241.67	7,500	1,812,525		Mar 13 04:25 PM
DUFFIELD DAVID A	10% Owner	Mar 03 '25	Sale	259.52	66,455	17,246,098	102,997	Mar 05 05:42 PM
Chakraborty Sayan	President, Prod. and Tech.	Feb 27 '25	Sale	265.50	6,056	1,607,858	111,324	Mar 03 07:32 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 03 '25	Proposed Sale	263.34	66,455	17,500,260		Mar 03 04:23 PM
SAYAN CHAKRABORTY	Officer	Feb 27 '25	Proposed Sale	271.09	6,056	1,641,721		Feb 27 04:26 PM

TEM

Tempus AI Inc

PODD

Insulet Corporation

WDAY

Workday Inc

Upgrade your FINVIZ experience